/
/
/

Concord Biotech Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)1,378.80
Volume (₹)63,724.00
High (₹)1,395.60
Upper Circuit1,643.60
Low (₹)1,372.10
Lower Circuit1,095.80
Prev Close1,369.70
52W High (₹)1,615.00
Price1,384.10
52W Low (₹)987.00

Share Market Cap & Key Ratios Overview

M.Cap (₹)14313.60 Cr
Div. Yield (%)0.55
PE Ratio51.98
Debt to Equity0.00
Price to Book5.27
Book Value192.81
EPS (TTM)26.32
Face Value1.00
ROE (%)13.54

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
CONCORDBIONSE
LTP
1W Low
1W High
Market cap (₹)
1746.4-13.6 (-0.77%)
1725.50
1776.60
4,24,466Cr
9023-317 (-3.39%)
8937.50
9431.50
2,46,222Cr
4580-76.9 (-1.65%)
4551.80
4682
1,76,301Cr
1124.7+7.2 (0.64%)
1107.30
1150.90
1,12,818Cr
2036.9+0.3 (0.01%)
2007.80
2069.20
1,10,823Cr
1314.6+13.6 (1.05%)
1300.20
1333.30
1,07,447Cr
1216+19 (1.59%)
1196.90
1250.70
1,03,471Cr
2335-33.5 (-1.41%)
2317.50
2426.80
97,850Cr
1662.9-30.1 (-1.78%)
1654.10
1715
96,836Cr
1953.2-3.3 (-0.17%)
1925.70
1964.90
89,629Cr
1384.1+22.7 (1.67%)
1335.50
1395.60
14,314Cr

Key Highlights of Concord Biotech Ltd Balance Sheet

Concord Biotech Ltd balance sheet discloses shareholders' funds of ₹10.46Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹10.46Cr, and the reserves and surplus of the company is ₹2009.29Cr.

The company has its non-current liabilities with total liabilities of ₹2236.54Cr as of 2026-03-31.

The current liabilities are ₹167.25Cr as of 2026-03-31. At the same time, current assets are ₹1245.22Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹85.63Cr and tangible assets of ₹786.41Cr, provided in the Concord Biotech Ltd financial statements.